Ten Washington state health organizations recently received grants of up to $15,000 from Fred Hutch Cancer Center’s Community ...

In 2024, Obliteride raised more than $9 million for research at Fred Hutch, contributing to more than $58 million raised since 2013. These funds have fueled urgently needed advances in cancer ...

At first glance, art and science might seem like opposite worlds — one driven by imagination and emotion, the other by data ...

Dr. Folashade Otegbeye, facility director of the Therapeutic Products Program at Fred Hutch, works to rapidly translate what ...

A study from Fred Hutch Cancer Center finds that some cancer patients' antibodies can boost their response to immunotherapy treatment.

A Fred Hutch Cancer Center outpatient complex serving more than 60,000 adult patients per year will be renamed the Sloan Clinic in recognition of Stuart and Molly Sloan, who have increased their total ...

Hepatic artery infusion (HAI) therapy offers a new approach for people whose colorectal cancer has spread to the liver. It allows physicians to deliver chemotherapy directly to the liver at doses up ...

Dr. Songli Zhu at work in the Tissue Culture room in the Gujral Lab at Fred Hutch. Zhu, Gujral and other researchers from Fred Hutch and the University of Washington just published a paper in Gut that ...

This year, researchers Megan Shen, PhD, and Mary L. “Nora” Disis, MD, of Fred Hutch Cancer Center and UW Medicine respectively, have each been recently awarded $300,000 in grants under the Rivkin ...

Fred Hutch news release clinical trial shows fecal microbiota transplantation helped with gut microbiome recovery in patients after stem cell transplantation ...